Bayer Aktiengesellschaft against Sanofi — live side-by-side technical comparison.
Prices as of 2026-10-13T15:35:07+00:00 UTC · updates daily
BAYN.DE leads 5 of the 5 windows we measure — over 1 month BAYN.DE is -8.3% and SNY -8.5%; over year to date BAYN.DE is +19.3% and SNY -19.3%.
| BAYN.DE | SNY | |
|---|---|---|
| Price | $44.15 | $39.12 |
| 1 day | +0.7%lead | -1.6% |
| 5 days | -0.7%lead | -1.1% |
| 1 month | -8.3%lead | -8.5% |
| 6 months | +8.2%lead | -16.7% |
| Year to date | +19.3%lead | -19.3% |
| 52-week position | 65% of range | 0% of range |
| 52-week range | $25.78–$53.92 | $39.07–$52.68 |
| vs 50-day average | below $48.05 | below $42.82 |
| vs 200-day average | above $43.24 | below $44.76 |
| RSI (14) | 29 | 27 |
| Next earnings | 2026-11-03 | 2026-10-30 |
BAYN.DE trades at $44.15, below its 50-day average of $48.05, and above the 200-day at $43.24. It sits at 65% of its 52-week range ($25.78–$53.92); 14-day RSI is 29, in oversold territory; an average session moves it about 3.1%. For levels, the first level overhead is $45.00 (1.9% away) and the first support below is $43.24 (2.1% down). On the checklist the page runs for every asset, 2 of 6 checks read bullish — the lean is bearish.
SNY trades at $39.12, below its 50-day average of $42.82, and below the 200-day at $44.76. It sits at 0% of its 52-week range ($39.07–$52.68); 14-day RSI is 27, in oversold territory; an average session moves it about 1.9%. For levels, the first level overhead is $40.00 (2.2% away) and the first support below is $35.00 (10.5% down). On the checklist the page runs for every asset, 0 of 6 checks read bullish — the lean is bearish.
BAYN.DE is the more volatile of the two — an average session moves it 3.1% against 1.9% for SNY, so an identical position size carries roughly 1.6× the daily risk.
The comparison turns on those levels: BAYN.DE clearing $45.00 or losing $43.24; SNY clearing $40.00 or losing $35.00. Until one of them gives way, the relative reading above stands.